Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| FLD | FOLD HOLDINGS INC | $29.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.30B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| PAC | PACIFIC AIRPORT GROUP | $10.28B | N/A | 83.00% | $4.4660 | N/A | N/A | 2 | ||
| CABA | CABALETTA BIO INC | $462.86M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AGMB | AGOMAB THERAPEUTICS NV | $636.50M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| IRON | DISC MEDICINE INC | $2.69B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $11.70B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LONA | LEONABIO INC | $65.20M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IMMX | IMMIX BIOPHARMA INC | $868.49M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| RBRK | RUBRIK INC | $17.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TLX | TELIX PHARMACEUTICALS LTD | $3.84B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| VKTX | VIKING THERAPEUTICS INC | $3.73B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BRSP | BRIGHTSPIRE CAPITAL INC | $563.03M | 14.38% | -266.70% | $0.1600 | $0.64 | 97% | 2 | ||
| ERAS | ERASCA INC | $5.55B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARVN | ARVINAS INC | $552.51M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLND | BLEND LABS INC | $333.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INFQ | INFLEQTION INC | $2.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACRS | ACLARIS THERAPEUTICS INC | $783.10M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IPX | IPERIONX LTD | $627.91M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADTN | ADTRAN HOLDINGS INC | $614.37M | N/A | 0.00% | $0.0900 | N/A | N/A | 0 | ||
| LTRX | LANTRONIX INC | $244.74M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CNTX | CONTEXT THERAPEUTICS INC | $32.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATHE | ALTERITY THERAPEUTICS LTD | $73.12M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SGRY | SURGERY PARTNERS INC | $1.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.84B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| BWAY | BRAINSWAY LTD | $545.58M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $11.58B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NKTX | NKARTA INC | $208.43M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BTGO | BITGO HOLDINGS INC | $899.22M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BIOA | BIOAGE LABS INC | $389.66M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GENB | GENERATE BIOMEDICINES INC | $2.02B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| ZGN | ERMENEGILDO ZEGNA NV | $3.12B | 1.21% | N/A | $0.1408 | $0.14 | 26% | 0 | ||
| VCYT | VERACYTE INC | $3.29B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ABVX | ABIVAX SA | $9.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TYRA | TYRA BIOSCIENCES INC | $1.31B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AKTS | AKTIS ONCOLOGY INC | $1.30B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| CEVA | CEVA INC | $816.75M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LTM | LATAM AIRLINES GROUP SA | $29.45B | 0.12% | 48.50% | $0.0596 | $0.06 | 1% | 0 | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $267.01M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KARD | KARDIGAN INC | $1.73B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| SLDB | SOLID BIOSCIENCES INC | $932.86M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| QNT | QUANTINUUM INC | $12.91B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| SVCO | SILVACO GROUP INC | $227.37M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRRO | KORRO BIO INC | $203.36M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CX | CEMEX SAB DE CV | $15.51B | 0.50% | 40.40% | $0.0312 | $0.05 | 8% | 1 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $1.33B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OMAB | CENTRAL NORTH AIRPORT GROUP | $4.77B | 5.16% | 167.10% | $2.5748 | $5.10 | 84% | 4 | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $320.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JHX | JAMES HARDIE INDUSTRIES PLC | $16.53B | N/A | 0.00% | $0.3000 | N/A | N/A | 4 | ||
| PAAS | PAN AMERICAN SILVER CORP | $21.21B | 1.08% | 18.70% | $0.1840 | $0.54 | 23% | 0 | ||
| CLS | CELESTICA INC | $39.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRVO | CERVOMED INC | $38.86M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KLRA | KAILERA THERAPEUTICS INC | $1.81B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| MAZE | MAZE THERAPEUTICS INC | $1.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $727.57M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MSLE | SATELLOS BIOSCIENCE INC | $203.18M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $894.23M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HELP | CYBIN INC | $803.93M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ELOX | ELOXX PHARMACEUTICALS INC | $63.57M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| SGMT | SAGIMET BIOSCIENCES INC | $676.29M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NVCT | NUVECTIS PHARMA INC | $781.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATTO | ATTOVIA THERAPEUTICS INC | $1.04B | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.